Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study.
Eur J Cancer
; 50(3): 611-21, 2014 Feb.
Article
in En
| MEDLINE
| ID: mdl-24295639
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Sulfonamides
/
Brain Neoplasms
/
Proto-Oncogene Proteins B-raf
/
Indoles
/
Melanoma
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Eur J Cancer
Year:
2014
Document type:
Article
Country of publication:
United kingdom